Ibd, Crohns Disease, Ulcerative Colitis, Precision Medicine, Research And Development.
biological markers for the molecular classification, diagnosis, and treatment response predictors for IBD. These biomarkers could potentially allow clinicians to assess disease severity for newly diagnosed and long-time patients, predict the onset of disease activity early, and change the course of